Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study was to determine the efficacy and safety of toripalimab combined with
radiotherapy in the treatment of oligometastatic nasopharyngeal carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Xinqiao Hospital of Chongqing
Collaborators:
Chongqing University Cancer Hospital Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Jiulongpo District People's Hospital Southwest Hospital, China The Ninth People's Hospital of Chongqing